GalenicaGALNF 80 EV-to-FCF is 17.84 as of Jun. 29, 2026, which is 17% below its 10-year median of 21.45. GuruFocus rates GALNF with a GF Score™ of 80/100 and a GF Value™ of $115.34. The stock has 1 warning sign investors should review. Among 75 Medical Distribution companies, Galenica ranks worse than 54.67% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Galenica's Enterprise Value is $5,426 Mil.
Galenica's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $304 Mil. Therefore, Galenica's EV-to-FCF for today is 17.84.
The historical rank and industry rank for Galenica's EV-to-FCF or its related term are showing as below:
GALNF'
s EV-to-FCF Range Over the Past 10 Years
Min: 11.57 Med: 21.45 Max: 30.39
Current: 18.03
During the past 13 years, the highest EV-to-FCF of Galenica was 30.39. The lowest was 11.57. And the median was 21.45.
GALNF's EV-to-FCF is ranked worse than 54.67% of 75
companies
in the Medical Distribution industry
Industry Median: 16.05
vs GALNF: 18.03
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Galenica's share price for today is $115.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Galenica's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $4.511.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Galenica EV-to-FCF Related Terms
Galenica EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Galenica's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Galenica's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galenica EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Galenica's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Galenica's EV-to-FCF falls into.
Galenica's current Enterprise Value is $5,426 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Galenica's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $304 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Galenica (GALNF) has a EV-to-FCF of 17.84 as of Jun. 29, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Galenica and its competitors. This is 17% below median its historical median of 21.45. Over the past decade, Galenica's EV-to-FCF has ranged from 11.57 to 30.39. According to the industry distribution chart, Galenica ranks #41 out of 75 companies in the Medical Distribution industry, placing it in the top 54.7%.
Is Galenica's EV-to-FCF too high?
Galenica's current EV-to-FCF of 17.84 is 17% below median its 10-year median of 21.45. Over the past 10 years, this metric has ranged from a low of 11.57 to a high of 30.39. The Medical Distribution industry median EV-to-FCF is 16.05. Galenica's value of 17.84 is 11.2% above this industry median. Based on the distribution chart, Galenica ranks #41 out of 75 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Galenica has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Galenica's EV-to-FCF compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Galenica ranks #41 out of 75 companies for EV-to-FCF. This places Galenica in the lower half of its industry. The industry median EV-to-FCF is 16.05. Galenica's value of 17.84 is 11.2% above this benchmark. Historically, Galenica's own EV-to-FCF has ranged from 11.57 to 30.39 over the past decade. While the company's 10-year median is 21.45 vs. the industry median of 16.05, Galenica has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 16.05, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galenica's current EV-to-FCF of 17.84 is 11.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Galenica and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 16.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galenica's current EV-to-FCF is 17.84, which is 17% below median its own 10-year median of 21.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galenica stock overvalued right now?
Galenica (GALNF) has a current EV-to-FCF of 17.84. The stock's GF Value™ is $115.34, compared to a current price of $115.00 — trading 0.3% below its estimated fair value. The current EV-to-FCF is 17.84, which is 17% below median its 10-year median of 21.45 and 11.2% above the Medical Distribution industry median of 16.05. Galenica's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Galenica (GALNF), the current EV-to-FCF is 17.84 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Galenica (GALNF) Overvalued in 2026?
Based on GuruFocus' analysis, Galenica stock appears to be undervalued.
The current stock price of $115.00 is trading 0.3% below its estimated GF Value™ of $115.34.
Key valuation signals for GALNF:
EV-to-FCF: 17.84 (17% below median its 10-year median of 21.45)
GF Value™: $115.34 vs. price of $115.00 (0.3% below fair value)
Industry Position: 11.2% above the Medical Distribution median (#41 of 75)
No single metric tells the full story. See the GALNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
80GF Score
Get the complete analysis for GALNF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GALNF has been successfully added to your 
